Texas Children's Hospital to Open 'Detransition Clinic' to Settle DOJ and State Investigation

The largest children's hospital in the United States has agreed to build something that does not yet exist anywhere in the country: a dedicated clinic for patients seeking to reverse gender transition procedures. The settlement, announced on May 15, 2026, concludes a three-year investigation and marks the first time a government agency has compelled a hospital to create a specific clinical program as a condition of resolving a legal dispute [1][2].

The Settlement Terms

Texas Children's Hospital reached the agreement jointly with the office of Texas Attorney General Ken Paxton and the U.S. Department of Justice. The settlement contains several components [1][2][3]:

• A $10 million payment to the state of Texas, resolving allegations that the hospital submitted false Medicaid billing codes for gender-affirming care procedures
• The termination of five physicians who provided gender-affirming care to minors, with a permanent prohibition on rehiring them
• The creation of a multidisciplinary "detransition clinic" that will provide care free of charge to patients for its first five years of operation
• An amendment to hospital bylaws requiring automatic relinquishment of privileges for any physician who violates Texas's prohibition on gender-affirming care for minors
• Implementation of additional compliance and ethics measures, though the full settlement text has not been publicly released [4]

The DOJ cited violations of the Federal Food, Drug, and Cosmetic Act, the False Claims Act, and federal fraud statutes [5]. The investigation focused on what the department characterized as "false billings to public and private payors" for pediatric procedures [5].

What Triggered the Investigations

The origins of this settlement trace to 2023. In March of that year, Attorney General Paxton announced an investigation into Texas Children's Hospital just as the state legislature was passing Senate Bill 14, which banned gender-affirming medical care for minors effective September 1, 2023 [6][2].

Separately, Dr. Eithan Haim, a surgeon who worked at Texas Children's during his residency, provided conservative journalist Christopher Rufo with patient records in May 2023 purporting to show that the hospital continued performing gender-related procedures on minors after publicly claiming it had ceased doing so [7]. Haim was subsequently indicted under HIPAA for the data leak, but the Trump administration's DOJ dropped those charges in January 2025 [8][9].

Texas Children's has maintained throughout the investigation that it never violated any law. In a statement accompanying the settlement, the hospital said it had been forced to "navigate an unconscionable campaign of mistruths and mischaracterizations" and that "all reviews and investigations continue to support the facts — we have been compliant with all laws" [2][4]. The hospital stated it settled to protect resources from "endless and costly litigation" rather than as an admission of wrongdoing [4].

The Hospital's Position Versus the State's Framing

The framing of the settlement differs sharply between the parties. Paxton called it a "historic" victory and framed the $10 million as damages for healthcare fraud [3]. The DOJ described it as a "landmark resolution" [5].

Texas Children's, by contrast, characterized the settlement as an economic calculation — the cost of continued litigation against both the state and federal government simultaneously exceeded what the hospital was willing to pay [4]. The hospital produced more than 5 million documents during the investigation and conducted internal reviews that, it says, showed compliance with all applicable laws [2].

Neither Paxton's office nor the hospital has released the names of the terminated physicians or a copy of the full settlement agreement [1][4].

A Clinic Without Precedent or Protocol

The most unusual provision of the settlement — the detransition clinic — raises immediate practical questions. No dedicated detransition clinic currently operates anywhere in the United States [1][3]. There are no board-certified specialty guidelines from the World Professional Association for Transgender Health (WPATH), the Endocrine Society, or the American Psychological Association defining "detransition medicine" as a clinical discipline [10].

WPATH's Standards of Care Version 8, published in 2022, addresses detransition only briefly, noting that clinicians should support patients who wish to detransition through individualized, multidisciplinary care — including hormone management, surgical consultation, mental health services, and voice therapy [10]. But WPATH does not contemplate a standalone institutional structure for such care.

Dr. Morissa Ladinsky, a Stanford pediatrics professor, raised a pointed question about the settlement's internal logic: the physicians best equipped to manage detransition care — those who understand the treatments being reversed — are the same five physicians the settlement requires the hospital to fire [1].

The settlement does not specify who will staff the clinic, what clinical protocols it will follow, or what timeline governs its opening [4][5].

What the Research Shows About Detransition

The academic literature on detransition has grown rapidly. According to OpenAlex data, peer-reviewed publications on the topic rose from 11 in 2019 to 158 in 2025, reflecting intensifying scientific and political interest [11].

Source: OpenAlex

Data as of Jan 1, 2026CSV

However, the research consistently shows low rates of detransition and even lower rates of regret. A 2024 systematic review by Feigerlova found that discontinuation of puberty blockers ranged from 1% to 7.6%, while discontinuation of gender-affirming hormone therapy ranged from 1.6% to 9.8% — but only 0.5% to 3.8% of those who stopped cited doubts about their gender identity rather than financial, logistical, or medical side-effect reasons [12]. A 2025 systematic follow-up study of 709 patients found a cumulative detransition rate of 1.87% [13].

Source: Systematic Reviews (Feigerlova 2024, Widenheim-Lenz 2025)

Data as of Mar 1, 2025CSV

A critical distinction in the literature: "detransition" encompasses multiple phenomena. A U.S. survey of 28,000 transgender adults found that 8% reported having detransitioned at some point, but 62% of those did so only temporarily, with the most common reasons being family pressure and societal stigma rather than regret about their transition [14]. A separate study found that among those who detransitioned, 82.5% reported at least one external driving factor [14].

Researchers have noted that the heterogeneity of definitions, small sample sizes, and short follow-up periods across studies make precise rate estimates difficult [15]. What is clear is that the population requiring clinical "detransition services" — as distinct from the much larger group who temporarily interrupted treatment for non-medical reasons — is small.

The Legal Questions

The settlement raises questions that legal scholars have not previously confronted in this form. The DOJ's authority to investigate Medicaid fraud is well-established under the False Claims Act. But the remedy — compelling a hospital to create an entirely new clinical program — is unusual.

Standard False Claims Act settlements typically involve financial penalties, compliance monitoring, and sometimes exclusion from federal healthcare programs. Requiring an institution to stand up a specific medical service as a condition of settlement does not have clear precedent in healthcare enforcement [5][3].

The constitutional questions are layered. The settlement was negotiated rather than court-ordered, meaning Texas Children's technically "agreed" to the clinic provision — but under the duress of combined state and federal investigative pressure. Whether a hospital's consent under such circumstances represents genuine voluntary agreement or constructive coercion is a question that could be tested if the settlement were ever challenged [2][4].

Texas state representative Ann Johnson criticized the arrangement as one that "opens the door to more state interference in medical practice" [2].

The Financial Calculus

Texas Children's Hospital serves more than 1 million patients annually and reported $9.1 billion in revenue in its most recent fiscal year. The $10 million penalty represents approximately 0.1% of annual revenue [3][4].

The cost of operating a small multidisciplinary clinic — even one providing free care — is likely modest relative to the hospital's overall budget, particularly if patient volumes are low. Brad Pritchett, CEO of Equality Texas, characterized the arrangement as "blackmailing a hospital system into creating a resource that no one is asking for" [2].

This framing suggests the clinic may function primarily as a low-cost political deliverable for both the state and federal government rather than a response to documented patient demand. The settlement does not cite any evidence of unmet need for detransition services, nor does it reference any waitlist or patient cohort requesting such care [3][5].

Patients Left Without Care

While the settlement creates a new clinic for a small and uncertain patient population, it leaves unaddressed the larger group of minors who were receiving or seeking gender-affirming care in Texas before services were suspended.

Texas Children's Hospital ceased providing gender-affirming care to minors in 2023, initially in response to Paxton's investigation and subsequently because of SB 14's statutory ban [6]. The Texas Supreme Court upheld SB 14 in June 2024, rejecting arguments that it violated parents' rights to seek medical care for their children [16].

Families affected by the ban face limited options. PBS News reported that families are traveling to neighboring states — New Mexico, Colorado, and others — for treatment, with some relocating entirely [17]. The Campaign for Southern Equality has compiled resources for affected Texas families seeking care elsewhere [18]. Some families report driving hundreds of miles and paying entirely out-of-pocket for continued care [17].

Additional legal risks complicate interstate care. Paxton's office has sought access to medical records of transgender patients receiving care out of state, and in February 2025 placed at least one physician under an injunction preventing prescriptions of puberty blockers or cross-sex hormones for the purpose of gender transition [18][6].

A March 2026 report found that Texas's ban has also created collateral damage: in El Paso, the restriction has compromised treatment for patients who require puberty blockers for non-gender-related conditions such as Bardet-Biedl syndrome, because physicians fear legal exposure [19].

Reactions and Broader Implications

Medical organizations have responded critically. The American Medical Association, American Academy of Pediatrics, American Psychological Association, and American Academy of Child and Adolescent Psychiatry all support evidence-based gender-affirming care for minors and oppose legislative restrictions on it [1][2].

Ash Hall of the ACLU of Texas said the organization is "disturbed with the state's relentless efforts to bully transgender youth and their families, doctors and communities who support them with evidence-based care" [2].

Andrea Segovia of the Transgender Education Network of Texas raised a broader concern about precedent: "We know that what starts in Texas expands to the rest of the country" [1].

From the opposing perspective, Paxton framed the settlement as accountability for what he characterized as healthcare fraud — billing the state for procedures he considers harmful to children [3]. The DOJ positioned it within a broader national investigation into "violations of federal law in connection with the provision of sex-rejecting procedures on minors" [5].

What Happens Next

The settlement leaves critical questions unanswered. No timeline has been announced for the clinic's opening. No staffing plan has been disclosed. No clinical protocols have been identified. The patient population the clinic would serve — those who received gender-affirming care at Texas Children's and now wish to reverse it — has not been quantified, and the hospital has not released data on how many minors it treated before suspending services [4][5].

The full text of the settlement agreement remains unreleased. Without it, the precise compliance mechanisms, monitoring structure, and enforcement triggers remain unknown. Whether this model — using fraud investigations to compel creation of politically aligned medical programs — will be replicated at other institutions depends in part on whether it faces legal challenge, and in part on whether the incoming political environment in Texas and Washington continues to prioritize this approach to healthcare enforcement.